ArticleJournal of skin cancer2025
Diagnostic Accuracy of Dermoscopic Characteristics in Cutaneous Squamous Cell Carcinoma: A Retrospective Analysis.
Article in Journal of skin cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aims to evaluate the diagnostic efficacy of dermoscopy for cutaneous squamous cell carcinoma (cSCC). Methods: A retrospective analysis was conducted on skin lesions diagnosed as cSCC via histopathology at the Department of Dermatology, Pingdu District, The Affiliated Hospital of Qingdao University, between January 2021 and August 2024 (case group). Lesions suspected of cSCC but ultimately diagnosed as other conditions served as the control group. The study compared disease progression and dermoscopic features between the two groups through chi-square test and logistic regression analysis, using histopathological results as the diagnostic reference standard. Results: The case group consisted of 41 lesions, while the control group comprised 18 lesions diagnosed with conditions including actinic keratosis, basal cell carcinoma, and keratoacanthoma. The clinical misdiagnosis rate was approximately 30.5%. Notably, a disease duration of less than 2 years (28/41, 68.29%), the presence of white circles (21/41, 51.22%) and blood spots (35/41, 85.37%), and a total of ≥ 5 dermoscopic features (19/41, 46.34%) were significantly more prevalent in the case group compared to the control group (both Conclusions: For patients with clinically suspected cSCC, a disease duration of less than 2 years and dermoscopic observation of white circles and blood spots provide substantial diagnostic value.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.